Immune therapy scores big win against lung cancer in study

MGN Online Photo
By  | 

CHICAGO (AP) - New research suggests that many more lung cancer patients may benefit from treatments that boost the immune system, which have scored some of their biggest wins until now in less common forms of the disease.

One study found using one of these drugs - Merck's Keytruda with usual chemotherapy greatly improved survival for people newly diagnosed with the most common type of cancer that had spread beyond the lungs.

That's a first, and it's expected to quickly set a new standard of care for about 70,000 patients each year in the United States.

Results were discussed Monday at an American Association for Cancer Research conference in Chicago and published by the New England Journal of Medicine.

(Copyright 2018 The Associated Press. All rights reserved. This material may not be published, broadcast, rewritten or redistributed.)

4/16/2018 9:44:32 AM (GMT -4:00)



 
Comments are posted from viewers like you and do not always reflect the views of this station. powered by Disqus